Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report)’s share price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 43.62 and traded as high as GBX 48. Beximco Pharmaceuticals shares last traded at GBX 48, with a volume of 419,866 shares traded.
Beximco Pharmaceuticals Stock Performance
The stock has a market capitalization of £229.06 million, a P/E ratio of 0.03 and a beta of 0.25. The company has a current ratio of 4.13, a quick ratio of 0.37 and a debt-to-equity ratio of 5.27. The company has a 50-day moving average price of GBX 43.80 and a two-hundred day moving average price of GBX 42.96.
Beximco Pharmaceuticals Company Profile
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.
Further Reading
- Five stocks we like better than Beximco Pharmaceuticals
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
